These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38671145)

  • 21. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
    Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
    J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
    Ricard F; Cimarelli S; Deshayes E; Mognetti T; Thiesse P; Giammarile F
    Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic response as assessed by
    Harrison DJ; Chi YY; Tian J; Hingorani P; Mascarenhas L; McCowage GB; Weigel BJ; Venkatramani R; Wolden SL; Yock TI; Rodeberg DA; Hayes-Jordan AA; Teot LA; Spunt SL; Meyer WH; Hawkins DS; Shulkin BL; Parisi MT
    Cancer Med; 2021 Feb; 10(3):857-866. PubMed ID: 33340280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.
    Muzahir S; Mian M; Munir I; Nawaz MK; Faruqui ZS; Mufti KA; Bashir H; Uddin N; Siddiqui N; Maaz AU; Mahmood MT
    Br J Radiol; 2012 Aug; 85(1016):e490-6. PubMed ID: 22215887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian Multicenter Study on Accuracy of
    Cistaro A; Cassalia L; Ferrara C; Quartuccio N; Evangelista L; Bianchi M; Fagioli F; Bisi G; Baldari S; Zanella A; Pillon M; Zucchetta P; Burei M; Sala A; Guerra L; Guglielmo P; Burnelli R; Panareo S; Scalorbi F; Rambaldi I; Piccardo A; Garaventa A; Familiari D; Fornito MC; Lopci E; Mascarin M; Altini C; Ferrari C; Perillo T; Santoro N; Borsatti E; Rubini G
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e267-e273. PubMed ID: 29739722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic rhabdomyosarcoma in a 6 years old patient evaluated by [
    Rivas-Navas D; Rudolphi-Solero T; Fernández-Fernández J; Villa-Palacios J; Ramos-Font C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(4):500016. PubMed ID: 38823555
    [No Abstract]   [Full Text] [Related]  

  • 31. Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET.
    Seshadri N; Wright P; Balan KK
    Clin Nucl Med; 2007 Oct; 32(10):787-9. PubMed ID: 17885359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.
    Dong P; Tian R; Li L; Su M
    Medicine (Baltimore); 2017 Dec; 96(49):e9067. PubMed ID: 29245317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
    Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Blase PE; Nievelstein RA; de Klerk JM
    Skeletal Radiol; 2014 Sep; 43(9):1231-6. PubMed ID: 24902511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
    Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
    Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
    Iagaru A; Goris ML
    Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1746. PubMed ID: 18648808
    [No Abstract]   [Full Text] [Related]  

  • 38. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S; Wang S; He K; Ma C; Fu H; Wang H
    Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
    Yang J; Zhen L; Zhuang H
    Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
    Wu LM; Chen FY; Jiang XX; Gu HY; Yin Y; Xu JR
    Eur J Radiol; 2012 Feb; 81(2):303-11. PubMed ID: 21145680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.